Clinical Trials Browser

Advanced Bladder Cancer × enfortumab vedotin × Genitourinary × Clear all

NCT06434350 2026-03-02

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

Phase 1/2 Recruiting

Advanced Bladder Cancer

NCT07346053 2026-01-16

Chrono-EVP

Phase 3 Not yet recruiting

Advanced Bladder Cancer